Automated, high-resolution cellular retention and uptake studies in vitro

Applied Radiation and Isotopes

Volumn 64, Issue 8, 2006, Pages 901-905

  Björke, Henrik ^a   Andersson, Karl ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cellular retention; Cellular uptake; Kinetics; Protein interactions

Indexed keywords

BIOASSAY; IMMUNOLOGY; PROTEINS; RADIOLOGY; TUMORS;

CELLULAR RETENTION; CELLULAR UPTAKE; KINETICS; PROTEIN INTERACTIONS;

CELLS;

CELL SURFACE RECEPTOR;

ARTICLE; AUTOMATION; CANCER CELL; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN INTERACTION; RADIOIMMUNOASSAY;

ANIMALS; ANTIBODIES; ANTIGENS, SURFACE; CARCINOMA; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; HUMANS; METABOLIC CLEARANCE RATE; RADIOIMMUNOASSAY; RADIOISOTOPE DILUTION TECHNIQUE; REPRODUCIBILITY OF RESULTS; ROBOTICS; SENSITIVITY AND SPECIFICITY;

EID: 33744552907     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2006.03.002     Document Type: Article

References (18)

1. Adams D.J., Wahl M.L., Flowers J.L., Sen B., Colvin M., Dewhirst M.W., Manikumar G., and Wani M.C. Camptothecin analogs with enhanced activity against human breast cancer cells. II. Impact of the tumor pH gradient. Cancer Chemother. Pharmacol. 57 2 (2005) 145-154
2. Andersson A., Holmberg A., Carlsson J., Carlsson J., Ponten J., and Westermark B. Binding of epidermal growth factor-dextran conjugates to cultured glioma cells. Int. J. Cancer 47 (1991) 439-444
3. Bjorke H., and Andersson K. Measuring the affinity of a radioligand with its receptor using a rotating cell dish with in situ reference area. Appl. Radiat. Isot. 64 (2006) 32-37
4. Braun A.H., Stark K., Dirsch O., Hilger R.A., Seeber S., and Vanhoefer U. The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan. Anticancer Drugs 16 (2005) 1099-1108
5. 76Br] (4 isothiocyanatobenzyl-ammonio)-bromo-decahydro-closo-dodecaborate (Bromo-DABI). Nucl. Med. Biol. 31 (2004) 205-211
6. 131I-EGF on cultured human glioma cells. J. Neurooncol. 9 (1990) 201-210
7. Carlsson J., Forssell-Aronsson E., Glimelius B., and Mattsson S. Therapy with radiopharmaceuticals. Acta. Oncol. 41 (2002) 623-628
8. Carlsson J., Forssell Aronsson E., Hietala S.O., Stigbrand T., and Tennvall J. Tumour therapy with radionuclides: assessment of progress and problems. Radiother. Oncol. 66 (2003) 107-117
9. Huber W. A new strategy for improved secondary screening and lead optimization using high-resolution SPR characterization of compound-target interactions. J. Mol. Recognit. 18 (2005) 273-281
10. 177Lu-labeled alpha-melanocyte stimulating hormone peptide analogues in a murine melanoma model. Nucl. Med. Biol. 32 (2005) 485-493
11. Mume E., Orlova A., Malmstrom P.U., Lundqvist H., Sjoberg S., and Tolmachev V. Radiobromination of humanized anti-HER2 monoclonal antibody trastuzumab using N-succinimidyl 5-bromo-3-pyridinecarboxylate, a potential label for immunoPET. Nucl. Med. Biol. 32 (2005) 613-622
12. Nordberg E., Steffen A.C., Persson M., Sundberg A.L., Carlsson J., and Glimelius B. Cellular uptake of radioiodine delivered by trastuzumab can be modified by the addition of epidermal growth factor. Eur. J. Nucl. Med. Mol. Imaging 32 (2005) 771-777
13. Olsson P., Lindstrom A., and Carlsson J. Internalization and excretion of epidermal growth factor-dextran-associated radioactivity in cultured human squamous-carcinoma cells. Int. J. Cancer 56 (1994) 529-537
14. Onell A., and Andersson K. Kinetic determinations of molecular interactions using Biacore-minimum data requirements for efficient experimental design. J. Mol. Recognit. 18 (2005) 307-317
15. 111In-labeled epidermal growth factor (EGF) bound to cultured A431 tumor cells. Nucl. Med. Biol. 27 (2000) 827-835
16. Tang L., Persky A.M., Hochhaus G., and Meibohm B. Pharmacokinetic aspects of biotechnology products. J. Pharm. Sci. 93 (2004) 2184-2204
17. Wei Q., Kullberg E.B., and Gedda L. Trastuzumab-conjugated boron-containing liposomes for tumor-cell targeting; development and cellular studies. Int. J. Oncol. 23 (2003) 1159-1165
18. 76Br]undecahydro-bromo-7,8-dicarba-nido-undecaborate(1-) ion. Nucl. Med. Biol. 31 (2004) 425-433